HelixBind's Grant - III Round

HelixBind raised a round of funding on July 01, 2016. Investors include National Institute of Allergy and Infectious Diseases.

HelixBind is focused on the diagnosis and management of bloodstream infections. HelixBind's patent pending Pathogen Identification (PID) platform will provide rapid detection and unequivocal identific…

Articles about HelixBind's Grant - III Round: